The House's Committee on Appropriations has added language to an FDA spending bill to prevent funds from being used to even evaluate germline editing experiments.
Bio-Rad scientist Jennifer Berman explains how ddPCR can help detect the basic efficiency of CRISPR/Cas9 and other genome editing technologies and more.
The scientists will use gut-on-a-chip technology to develop probiotics that can sense and respond to pathogenic microbes that have made their way into a person's GI system.
The pipeline identifies interesting mutants with PCR and sequencing and allows the creation of multiplexed mutants.
Doudna and Baltimore lead a group of experts tasked with identifying issues to address at an international summit on human gene editing and a subsequent study.
In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.
An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.
Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.
US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.